Altimmune, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of Altimmune, Inc.'s 2022 Annual Meeting of Stockholders held on September 29, 2022. The record date for the meeting was August 12, 2022, with 49,024,358 shares of common stock outstanding and entitled to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 36,609,662 shares were present or represented by proxy, representing 74.68% of outstanding shares, establishing a quorum. The voting outcomes were as follows:
- Proposal 1 (Election of Directors): All eight nominees were elected. However, significant "Withhold" votes were cast for three directors: David J. Drutz (4,063,963), John M. Gill (4,063,581), and Wayne Pisano (4,298,514). The remaining five directors received fewer than 107,000 "Withhold" votes each.
- Proposal 2 (Ratification of Auditors): The appointment of Ernst & Young LLP was ratified with 36,417,212 votes "For" versus 103,172 "Against".
- Proposal 3 (Say-on-Pay): The advisory vote on executive compensation received 17,483,146 votes "For" and 6,452,469 votes "Against".
- Proposal 4 (Adjournment Authorization): The proposal to authorize adjournment to solicit additional proxies passed with 26,130,153 votes "For" and 10,300,107 votes "Against".
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the reasons behind the high "Withhold" vote percentages for directors David J. Drutz, John M. Gill, and Wayne Pisano.
- Confirm the final approval status of the "Say-on-Pay" proposal given the significant number of "Against" votes (approximately 27% of votes cast).
- Review the company's subsequent 10-K or 10-Q filings for financial performance data not included in this 8-K.